The return of pertussis: Who is responsible? What can be done?

Israel Medical Association Journal

Volumn 8, Issue 5, 2006, Pages 301-307

  Hochwald, Ori ^a,b   Bamberger, Ellen ^a,b   Srugo, Isaac ^a,b  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antibiotics; Epidemiology; Pertussis; Polymerase chain reaction

Indexed keywords

ACELLULAR VACCINE; ANTIBIOTIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN; IMMUNOGLOBULIN; PERTUSSIS VACCINE; SALBUTAMOL;

ABDOMINAL CRAMP; AGE DISTRIBUTION; ARTICLE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; BRAIN DISEASE; CAUSE OF DEATH; CLINICAL ASSESSMENT; CLINICAL FEATURE; COST BENEFIT ANALYSIS; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; GASTROINTESTINAL IRRITATION; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; HYPOTONIC HYPORESPONSIVE EPISODE; INCIDENCE; INFECTION COMPLICATION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTRAUTERINE INFECTION; ISRAEL; KERNICTERUS; LABORATORY DIAGNOSIS; LIVER TOXICITY; MASS IMMUNIZATION; MAXIMUM TOLERATED DOSE; MORBIDITY; MORTALITY; NAUSEA; PASSIVE IMMUNIZATION; PERTUSSIS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; SEIZURE; SENSITIVITY ANALYSIS; SERODIAGNOSIS; SINGLE DRUG DOSE; TREATMENT DURATION; UNITED STATES; VOMITING;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; EUROPE; HISTORY, 17TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; ISRAEL; PERTUSSIS VACCINE; UNITED STATES; WHOOPING COUGH;

EID: 33744464242     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Pertussis - United States, 1997-2000. MMWR 2002;51(4):73-6.
2. Heininger U, Schmidt-Schlapfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 2000;105(3): E31.
3. Muller FM, Hoppe JE, Wirsing von Konig CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997;35(10):2435-43.
4. Lugauer S, Heininger U, Cherry JD, Stehr K. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr 2002;161(3):142-6.
5. Hewlett EL, Edwards KM. Clinical practice. Pertussis - not just for kids. N Engl J Med 2005;352(12):1215-22.
6. Bordet JGO. Le microbe de la coqueluche. Annu Inst Pasteur (Paris) 1906;20:48-68.
7. Black S. Epidemiology of pertussis. Pediatr Infect Dis J 1997;16(4 Suppl):S85-9.
8. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997:46(RR-7):1-25.
9. Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003;21(17-18): 2003-14.
10. Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegrist CA. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 1999;354(9195):2063-8.
11. Ekwueme DU, Strebel PM, Hadler SC, Meltzer MI, Allen JW, Livengood JR. Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997. Arch Pediatr Adolesc Med 2000;154(8):797-803.
12. Moore DL, Le Saux N, Scheifele D, Halperin SA. Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993-2002. Pediatr Infect Dis J 2004;23(6):568-71.
13. Ntezayabo B, De SG, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J 2003;22(1):22-7.
14. Girard DZ. Which strategy for pertussis vaccination today? Paediatr Drugs 2002;4(5):299-313.
15. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988;296(6622):612-14.
16. Salmaso S, Mastrantonio P, Tozzi AE, et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001;108(5):E81.
17. Tozzi AE, Rava L, Ciofi degli Atti ML, Salmaso S. Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics 2003;112(5):1069-75.
18. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003;3(7):413-18.
19. Heininger U. Recent progress in clinical and basic pertussis research. Eur J Pediatr 2001;160(4):203-13.
20. Weir E. Resurgence of Bordetella pertussis infection. CMAJ 2002; 167(10):1146.
21. Skowronski DM, De SG, MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002; 185(10):1448-53.
22. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28(6):1230-7.
23. Fine PE, Clarkson JA. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet 1982;i(8273):666-9.
24. Pertussis deaths - United States, 2000. MMWR 2002;51(28): 616-18.
25. Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000;49(RR-13):1-8.
26. Crowcroft NS, Britto J. Whooping cough - a continuing problem. Br Med J 2002;324(7353):1537-8.
27. Gay NJ, Miller E. Pertussis transmission in England and Wales. Lancet 2000;355(9214):1553-4.
28. Gilberg S, Njamkepo E, Du CI, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002;186(3):415-18.
29. Central Bureau of Statistics Israel. Infectious Diseases - Whooping cough HEALTH/Obligatory notifications of cases of infectious diseases. available at:http://www.cbs.gov.il/data/E1050404110517.csv. Accessed last on 3/2005.
30. Klement E, Uliel L, Engel I, et al. An outbreak of pertussis among young Israeli soldiers. Epidemiol Infect 2003;131(3):1049-54.
31. Srugo I, Benilevi D, Madeb R, et al. Pertussis infection in fully vaccinated children in day-care centers, Israel. Emerg Infect Dis 2000;6(5):526-9.
32. von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002;2(12):744-50.
33. NIP Publications. Guidelines for the Control of Pertussis Outbreaks. Available at http://www.cdc.gov/nip/publications/pertussis/guide.htm. CDC 2004; last accessed on 3/2005.
34. Cherry JD. Pertussis in adults. Ann Intern Med 1998;128(1):64-6.
35. Qin X, Turgeon DK, Ingersoll BP, et al. Bordetella pertussis PCR: simultaneous targeting of signature sequences. Diagn Microbiol Infect Dis 2002;43(4):269-75.
36. Dragsted DM, Dohn B, Madsen J, Jensen JS. Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J Med Microbiol 2004;53(Pt 8):749-54.
37. Forsyth KD, Campins-Marti M, Caro J, et al. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis 2004;39(12):1802-9.
38. Pichichero ME, Rennels MB, Edwards KM, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 2005;293(24):3003-11.
39. Campins-Marti M, Cheng HK, Forsyth K, et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001;20(5-6):641-6.
40. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 2005;(1): CD004404.